Xilio Development Capital Expenditures Over Time

XLO Stock  USD 1.28  0.34  36.17%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Xilio Development Performance and Xilio Development Correlation.
To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.
  
As of the 23rd of December 2024, Capital Expenditures is likely to drop to about 461.7 K.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.55)
Revenue Per Share
0.105
Return On Assets
(0.53)
Return On Equity
(1.71)
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Capital Expenditures Analysis

Compare Xilio Development and related stocks such as Connect Biopharma, Tyra Biosciences, and RAPT Therapeutics Capital Expenditures Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
CNTB1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.1 M2.3 M47.5 M4.3 M294 K279.3 K
TYRA20 K20 K20 K20 K20 K20 K20 K20 K20 K20 K312 K661 K559 K770 K510.8 K
RAPT1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M3.5 M888 K398 K755 K845 K1.1 M986.9 K
MLYS0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EWTX180 K180 K180 K180 K180 K180 K180 K180 K180 K180 K203 K668 K5.5 M5.7 MM
ANEB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ANTX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
AVTE181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K195 K142 K140.8 K
ADAG514.7 K514.7 K514.7 K514.7 K514.7 K514.7 K514.7 K514.7 K514.7 K151.8 K935.2 K2.5 M690.9 K85 K80.8 K
MOLN1.5 M1.5 M1.5 M1.5 M546.1 K1.4 M1.1 M500 K867 K1.9 M1.7 M1.3 M1.4 M808 K1.3 M
MNOV10.5 K6.1 K83.4 K41.6 K3.5 K2.3 K84.5 K10.2 K10.2 K11.3 K36.5 K28.7 KK21.3 K20.2 K
CSBR0.0519 K57 K234 K119 K322 K766 K1.2 M834 K2.2 M3.3 M2.4 M2.9 M836 K610 K

Xilio Development and related stocks such as Connect Biopharma, Tyra Biosciences, and RAPT Therapeutics Capital Expenditures description

Capital Expenditures are funds used by Xilio Development to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Xilio Development operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

My Equities

My Current Equities and Potential Positions

Xilio Development
XLO
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 1.28
When determining whether Xilio Development offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xilio Development's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xilio Development Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xilio Development Stock:
Check out Xilio Development Performance and Xilio Development Correlation.
To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Xilio Development technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Xilio Development technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Xilio Development trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...